Yes, there would be a bounceback. But will it be for all the stocks? I do not think so.

Vedanta, Hindalco Industries, Tata Steel and Steel Authority of India advancing 2-4%.

We would prefer some of the mid-cap stocks.

It is more of a bottoms up kind of an approach within the pharmaceutical sector.

In total, 22 of the Nifty 50 companies saw their EPS decline in the range of Rs 0.2 to Rs 32.2.

Overall, HFC is a segment where you should venture only if you are a high-risk guy, says Sofat

The correction in the market which began in September has made stocks cheaper.

“Expect a cut in earnings for all the wholesale NBFCs going forward.”

"We believe Hero could be one stock which provides a decent risk reward at current levels."

"We will like to see 10% more correction in cement stocks before building a position."

"The privatisation of banks looks quite unlikely in the current political scenario."

Eicher, with its current market cap of around $12 bn, would not feel much stress from Ducati acquisition.

“Other than these 3 stocks, it is better to avoid the pharma sector in general.”

I am pretty confident that going forward despite that short-term challenges of GST, one is likely to make decent amount of money from curre...

It is duopoly business with NSDL and CDSL being the only two players right now in the market.

From one, one-and-a-half year risk reward perspective, TCS will continue to be bullish going forward because the stability of business is l...

"I would rather look at focussing more on B2B kind of businesses, currently something like a Power Finance Corporation."